Epirium Bio, Inc.
Author: Michael
Epirium Bio, Inc.
Biotechnology firm Vasa Therapeutics announce
Biotechnology firm Vasa Therapeutics announce
Alzheon, Inc.
Alzheon, Inc.
EyePoint Pharmaceuticals announced that its indep
Biotechnology firm Oligomerix, Inc.
Vincere lands MJFF grant to support mitochondria
Proposed NIH cuts may not stand, but renewed deb